In this Issue:
Gene mutation and mesothelioma pathogenesis
Next-generation sequencing in MPM
VAT pleurectomy vs. talc pleurodesis in MPM
Accelerated induction IMRT followed by EPP for MPM
Continuing crizotinib beyond progression in ALK-positive NSCLC
Immunotherapies in NSCLC
Tecemotide in unresectable stage III NSCLC
Please login below to download this issue (PDF)